- Home
- PMCB vs MEGL Comparison
PMCB vs MEGL Comparison
Compare PMCB & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- MEGL
- Stock Information
- Founded
- PMCB 1996
- MEGL 2016
- Country
- PMCB United States
- MEGL Hong Kong
- Employees
- PMCB N/A
- MEGL N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- MEGL Finance: Consumer Services
- Sector
- PMCB Health Care
- MEGL Finance
- Exchange
- PMCB Nasdaq
- MEGL Nasdaq
- Market Cap
- PMCB 6.6M
- MEGL 6.8M
- IPO Year
- PMCB N/A
- MEGL 2022
- Fundamental
- Price
- PMCB $0.94
- MEGL $1.45
- Analyst Decision
- PMCB
- MEGL
- Analyst Count
- PMCB 0
- MEGL 0
- Target Price
- PMCB N/A
- MEGL N/A
- AVG Volume (30 Days)
- PMCB 51.4K
- MEGL 36.7K
- Earning Date
- PMCB 12-12-2025
- MEGL 12-11-2025
- Dividend Yield
- PMCB N/A
- MEGL N/A
- EPS Growth
- PMCB N/A
- MEGL N/A
- EPS
- PMCB 0.01
- MEGL N/A
- Revenue
- PMCB N/A
- MEGL $1,296,394.00
- Revenue This Year
- PMCB N/A
- MEGL N/A
- Revenue Next Year
- PMCB N/A
- MEGL N/A
- P/E Ratio
- PMCB $152.54
- MEGL N/A
- Revenue Growth
- PMCB N/A
- MEGL N/A
- 52 Week Low
- PMCB $0.80
- MEGL $1.02
- 52 Week High
- PMCB $2.42
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- PMCB 40.17
- MEGL 47.85
- Support Level
- PMCB $0.92
- MEGL $1.37
- Resistance Level
- PMCB $1.03
- MEGL $1.46
- Average True Range (ATR)
- PMCB 0.04
- MEGL 0.06
- MACD
- PMCB -0.01
- MEGL -0.01
- Stochastic Oscillator
- PMCB 8.34
- MEGL 45.71
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.